Ironwood Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ironwood Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8% to $442,735,000. Profit margin reached -226%. Total operating expenses were $1,283,380,000.
Profit Margin
| 2014 | 76.43M | -189.61M | -248.07% |
|---|---|---|---|
| 2015 | 149.55M | -142.66M | -95.4% |
| 2016 | 273.95M | -81.70M | -29.83% |
| 2017 | 298.27M | -116.93M | -39.2% |
| 2018 | 346.63M | -282.36M | -81.46% |
| 2019 | 428.41M | -15.31M | -3.57% |
| 2020 | 389.52M | 106.17M | 27.26% |
| 2021 | 413.75M | 528.44M | 127.72% |
| 2022 | 410.59M | 175.06M | 42.64% |
| 2023 | 442.73M | -1.00B | -226.37% |
IRWD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 442.73M | 410.59M | 413.75M | 389.52M | 428.41M | 346.63M | 298.27M | 273.95M | 149.55M | 76.43M |
Cost of revenue | 1.57M | 1.41M | 1.52M | 3.13M | 23.87M | 32.75M | 19.40M | 1.86M | 12K | 25.58M |
Gross profit | 441.16M | 409.17M | 412.23M | 386.38M | 404.53M | 313.88M | 278.87M | 272.08M | 149.54M | 50.85M |
Operating exp. | ||||||||||
Research and development | 116.08M | 44.26M | 70.40M | 88.06M | 115.04M | 166.50M | 148.22M | 139.49M | 108.74M | 101.89M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.28B | 160.25M | 181.53M | 228.06M | 287.49M | 415.90M | 387.56M | 313.75M | 233.99M | 220.22M |
Operating income | -945.43M | 250.33M | 232.25M | 142.94M | 120.12M | -238.89M | -77.38M | -51.87M | -102.08M | -169.37M |
Other income (expenses), net | -2.63M | 2.08M | -31.60M | -34.07M | -61.18M | -145.61M | -71.16M | -2.05M | -40.58M | -20.24M |
Income before tax | -948.06M | 252.42M | 200.65M | 108.86M | 58.94M | -282.36M | -116.93M | -81.70M | -142.66M | -189.61M |
Income tax expense | 83.49M | 77.35M | -327.79M | 2.68M | 74.25M | -5.75M | 34.25M | 37.98M | 19.02M | 8.57M |
Net income | -1.00B | 175.06M | 528.44M | 106.17M | -15.31M | -282.36M | -116.93M | -81.70M | -142.66M | -189.61M |
Earnings per share | ||||||||||
Basic EPS | -6.45 | 1.13 | 3.26 | 0.67 | -0.09 | -1.85 | -0.79 | -0.56 | -1 | -1.39 |
Diluted EPS | -6.45 | 0.94 | 3.21 | 0.66 | -0.09 | -1.85 | -0.78 | -0.56 | -1 | -1.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |